As of today (2024-06-09), Marizyme's share price is $0.093. Marizyme's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.23. Hence, Marizyme's Price to Tangible Book Ratio of today is .
The historical rank and industry rank for Marizyme's Price-to-Tangible-Book or its related term are showing as below:
During the past 13 years, Marizyme's highest Price to Tangible Book Ratio was 96.00. The lowest was 0.23. And the median was 0.92.
MRZM's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.77 * Ranked among companies with meaningful Price-to-Tangible-Book only.
A closely related ratio is called PB Ratio. As of today, Marizyme's share price is $0.093. Marizyme's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-0.08. Hence, Marizyme's P/B Ratio of today is .
Marizyme Price-to-Tangible-Book Historical Data
The historical data trend for Marizyme's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Marizyme's Price-to-Tangible-Book
For the Biotechnology subindustry, Marizyme's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Marizyme's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Marizyme's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Marizyme's Price-to-Tangible-Book falls into.
Marizyme Price-to-Tangible-Book Calculation
Marizyme's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Marizyme Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Marizyme's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MRZM has been successfully added to your 